|

177Lu-DOTA-SNA040 Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • SmartNuclide Biopharma1

Indications

  • Advanced Solid Tumors (Such as Cholangiocarcinoma)1
  • Advanced Solid Tumors (Such as Pancreatic Cancer)1
  • Advanced Solid Tumors (Such as Adenocarcinoma at the Gastroesophageal Junction)1
  • Advanced Solid Tumors (Such as Gastric Cancer)1
  • Cancer1

Other1 trial

A IIT Study of 177Lu-DOTA-SNA040
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.